Large iron gyroid (1.3 x 1.0 cm). Credit: ALCHEMY EPFL CC BY SA EPFL scientists have created a breakthrough 3D printing method that uses hydrogels as templates to produce ultra-dense, durable metals ...
Researchers have developed a new battery recycling method that uses a cell’s own stored energy to process materials and recover key metals. The technique involves triggering a controlled thermal ...
Researchers have developed a method to break down PET, one of the world’s most widely used plastics, for sustainable recycling using mechanical forces instead of heat or harsh chemicals. The high ...
Scientists at the Environmental Protection Agency found that they could develop methods to identify traces of the medication if necessary — a practice long sought by the anti-abortion movement. Credit ...
Bastian, a 7-year-old rat terrier mix from Levittown, N.Y., is the winner of PEOPLE's World's Cutest Rescue Dog Contest Presented by the PEDIGREE® Brand Kelli Bender is the Pets Editor at PEOPLE. She ...
With the city of Long Beach set to host 18 events as part of the 2028 Olympic Games and 2029 Paralympic Games, the most for any city other than Los Angeles, local leaders are searching for creative ...
Abstract: Accurate detection and recognition of elevator buttons are essential for autonomous service robots. However, issues such as missed and false detections, caused by lighting, reflections, and ...
Want to master beef ribs on a small grill? This video walks you through the step-by-step process of smoking beef ribs in a Weber Go Anywhere. Get that rich, smoky bark and fall-off-the-bone meat ...
Biophysics and Cellular Biotechnology Department, Carol Davila University of Medicine and Pharmacy, 8 Eroii Sanitari Blvd., Bucharest 050474, Romania Excellence Center for Research in Biophysics and ...
I started the Browser Node using the org.openqa.selenium.grid.node.httpd.NodeServer class and need to stop the NodeServer in certain use cases. I tried using the stop() method to stop the NodeServer, ...
Vertex Pharmaceuticals is offering Enlaza Therapeutics more than $2 billion in biobucks through a multitarget drug discovery deal aiming to create new T-cell engagers and small-format drug conjugates.